Our Team

Dr. Philip LeeChemistry, PhD Biochemistry

Dr. Philip Lee stands as a towering figure in the realm of biochemistry, with an illustrious academic background and a trailblazing career path. Armed with a Master's degree in Biochemistry and a Doctorate in Biochemistry from Columbia University, Dr. Lee embodies the fusion of theoretical understanding and practical innovation that drives scientific progress.

Dr. Lee honed his expertise during his tenure at Becton Dickinson(BD), where he spent seven years immersed in the intricate world of biochemical research and development. It was during this period that Dr. Lee's passion for innovation and discovery truly flourished, laying the foundation for his future endeavors.

Driven by a relentless pursuit of excellence, Dr. Lee ventured into entrepreneurship and founded Plenum Scientific Research Lab Inc in 1969. His vision was clear: to push the boundaries of biochemistry and catalyze groundbreaking discoveries that would revolutionize the field.

Under Dr. Lee's leadership, Plenum Scientific has emerged as a hub of innovation, spearheading the development of over 100 pioneering products that have left an indelible mark on biochemistry. These products, including MDP (Methylene Diphosphate), tRNA (Transfer RNA), and Adenosine Diphosphate lithium salt, have found diverse applications across a myriad of industries, from pharmaceuticals to biotechnology:

1. MDP (Methylene Diphosphate): MDP, short for Methylene Diphosphate, stands as a cornerstone in Dr. Philip Lee's repertoire of biochemical innovations. This compound, meticulously developed through Dr. Lee's expertise, possesses remarkable properties that have revolutionized various sectors.

MDP's immunostimulatory properties hold promise for vaccine development and cancer immunotherapy by activating innate immune pathways. In medicinal chemistry, MDP serves as a versatile scaffold for novel therapeutics, targeting a wide range of diseases. Additionally, in biotechnology, MDP facilitates enzyme engineering and biocatalysis, enhancing activity and specificity for sustainable processes.

2. tRNA (Transfer RNA): As a crucial component of the protein synthesis process, tRNA plays a pivotal role in translating genetic information into functional proteins. Dr. Lee's innovative formulations of tRNA have paved the way for advancements in gene editing, synthetic biology, and beyond.

3. Adenosine Diphosphate lithium salt: This innovative compound combines the biochemical properties of Adenosine Diphosphate with the unique characteristics of lithium salt. As a result, it finds applications across a wide range of biochemical research, from cellular signaling pathways to enzyme kinetics and drug discovery. Dr. Lee's groundbreaking research has unlocked the potential of this compound, opening new avenues for understanding and manipulating cellular processes.

Dr. Philip Lee's contributions to the field of biochemistry transcend mere scientific inquiry; they represent a testament to the transformative power of innovation and perseverance. As he continues to push the boundaries of scientific discovery, Dr. Lee remains committed to shaping a future where biochemistry holds the key to addressing some of society's most pressing challenges.

Shajadi ParvinCEO & President

As President and CEO, Shajadi Parvin stands at the helm of transformative change in the pharmaceutical landscape, blending academic excellence with a wealth of industry experience. Armed with a PhD in Pharmaceuticals from Temple University and a Diploma in Clinical Research Associate, Parvin's journey epitomizes dedication and innovation.

Parvin's career trajectory began with notable stints at Glaxo Pharmaceuticals and Pfizer, where she honed her skills across diverse domains. Her expertise spans the opthalmic and vaccine divisions, where she played a pivotal role in driving forward cutting-edge research and development initiatives.

In 2003, Parvin embarked on a new chapter, joining Plenum with a fervent determination to catalyze breakthrough advancements. Her leadership ushered in a new era of innovation, marked by the inception of major projects focusing on Transfer RNA (tRNA) and Methylene Diphosphate (MDP).

Under Parvin's guidance, these projects flourished, yielding groundbreaking discoveries and technological advancements. From enhancing drug delivery mechanisms to bolstering immune response, Parvin's visionary leadership propelled Plenum to the forefront of pharmaceutical innovation.

Beyond her professional endeavors, Parvin remains deeply committed to fostering positive change in the community. Through initiatives aimed at healthcare access and education, she channels her passion for social responsibility, leaving an indelible impact on society.

As President and CEO, Shajadi Parvin continues to redefine the boundaries of pharmaceutical innovation, paving the way for a future where healthcare is not just a service, but a beacon of hope and healing.

Dr. Gee CeeVice President

Dr. Gee Cee, a luminary in the pharmaceutical realm, brings forth a distinguished academic background and an illustrious career path. Armed with a Doctorate in Pharmaceutical Chemistry (PhD) and a Doctor of Chemical Research Administration (DCRA) from Toronto University, Dr. Cee epitomizes the amalgamation of academic rigor and industrial acumen.

Embarking on his journey in the pharmaceutical domain, Dr. Cee honed his expertise through diverse roles in esteemed organizations such as Pfizer and various other pharmaceutical companies. This experiential learning ground equipped him with invaluable insights into the intricacies of drug development and manufacturing.

Driven by an entrepreneurial spirit and a fervent desire to innovate, Dr. Cee founded the American Institute of Pharmaceutical Technology (AIPT), a pioneering institution dedicated to advancing pharmaceutical education and research. Through AIPT, Dr. Cee fostered a culture of excellence, nurturing the next generation of pharmaceutical leaders and driving innovation in drug discovery and development.

In a strategic move that underscored his visionary leadership, Dr. Cee acquired Plenum in 2000, marking a significant milestone in his entrepreneurial journey. At Plenum, Dr. Cee spearheaded the development of a myriad of bio-pharmaceutical products, leveraging cutting-edge technology and scientific expertise to address unmet medical needs.

Beyond his entrepreneurial endeavors, Dr. Cee is deeply committed to serving the community through the MAA Foundation, a non-profit organization dedicated to enhancing healthcare access and promoting education in underserved communities. Through initiatives ranging from medical outreach programs to scholarship opportunities, Dr. Cee's philanthropic endeavors reflect his unwavering commitment to social responsibility and positive societal impact.

As Vice President, Dr. Gee Cee continues to champion innovation and excellence in the pharmaceutical industry, driving transformative change and shaping the future of healthcare with a chemical vision.

Dr. Muzharool IDirector at Plenum

Dr. Muzharool I stands as a beacon of expertise and leadership at Plenum, driving forward the company's innovative endeavors with a wealth of knowledge and experience. With a Master's in Pharmacy from the University of Japan and a PhD from Toronto University, Dr. I embodies a fusion of international education and specialized research.

Joining Plenum in 2006, Dr. I brought with him a passion for pushing the boundaries of pharmaceutical science and a dedication to excellence. As Director of the company, he oversees the implementation of cutting-edge research initiatives and strategic development projects.

Under Dr. I's guidance, Plenum continues to thrive as a center of innovation, with a focus on pioneering solutions to address critical healthcare challenges. His vision and expertise drive forward the company's mission to improve patient outcomes and advance the field of pharmaceuticals.

With Dr. Muzharool I at the helm, Plenum remains at the forefront of pharmaceutical innovation, poised to make significant contributions to global healthcare.

Pinesh PatelDirector at Plenum

We are proud to introduce Pinesh Patel, the esteemed Director of our team and a distinguished metrologist based in Ontario, Canada. With extensive expertise in the science of measurement, Pinesh has significantly contributed to the advancement of precision and accuracy in various industries.

Pinesh Patel brings a wealth of knowledge and experience to our organization, having dedicated his career to the field of metrology. His work in Ontario has been pivotal in setting high standards for measurement practices, ensuring that industries adhere to the most stringent quality controls. 

- Expert in Metrology: Pinesh's expertise spans the full spectrum of measurement science, including the development and calibration of measurement standards, as well as the implementation of innovative measurement techniques.

- Quality Assurance: He has played a crucial role in enhancing quality assurance processes across multiple sectors, including manufacturing, healthcare, and environmental monitoring.

- Industry Leadership: As a thought leader, Pinesh has been actively involved in various professional organizations and has contributed to numerous publications and conferences, sharing his insights and advancements in metrology.

Pinesh Patel's vision for our team is to continue pushing the boundaries of precision and reliability in measurement. His leadership is characterized by a commitment to excellence, fostering a culture of continuous improvement and innovation.

We are fortunate to have Pinesh Patel at the helm, guiding our team towards new heights in metrological excellence. His contributions not only elevate our organization but also have a lasting impact on the industries we serve.